Karolinska Institutet Longitudinal Study Proves "Metabolically Healthy" Obesity in Children Still Carries High Risk for Adult Diabetes

Karolinska Institutet study finds children with "healthy" obesity still face 18x higher diabetes risk by age 30, proving early treatment is essential for all.

By: AXL Media

Published: Mar 24, 2026, 5:37 AM EDT

Source: Information for this report was sourced from Karolinska Institutet

Challenging the Assumption of Metabolically Healthy Obesity

There has long been a medical debate regarding whether children who live with obesity but maintain normal blood pressure, liver values, and lipid profiles require immediate clinical intervention. New research from Karolinska Institutet, published in JAMA Pediatrics, provides a definitive answer: they do. The study tracked 7,200 children aged 7 to 17 who began obesity treatment in Sweden, following them into their 30s. The findings show that "Metabolically Healthy Obesity" (MHO) is a misnomer, as these children still face a significantly elevated risk of chronic illness compared to the general population. Professor Claude Marcus emphasized that a lack of abnormal blood test results in childhood is not a sufficient shield against future disease.

A Stark Statistical Increase in Adult Morbidity

By the age of 30, the health outcomes for children in the MHO group were significantly worse than those of their peers with healthy weights. Nine percent of those who had MHO as children developed type 2 diabetes, compared to just 0.5 percent of the control group—an 18-fold increase. Similar trends were observed in other cardiovascular risk factors: 11 percent developed high blood pressure, and 5 percent developed abnormal blood lipids. While these figures were lower than those for children who already showed metabolic impairment in youth (the MUO group), they represent a massive leap in risk that traditional diagnostic screenings might otherwise miss.

The Efficacy of Early Treatment Response

The study also evaluated how children responded to lifestyle-focused obesity treatments and how that response dictated their future health. Encouragingly, a positive response to treatment during childhood—defined as a reduction in BMI or improvement in health habits—was linked to a reduced risk for all studied diseases by age 30. Crucially, the benefits of treatment were equally significant for both the "metabolically healthy" and "metabolically unhealthy" groups. This suggests that the biological "imprinting" of obesity can be mitigated if the condition is addressed early, regardless of the child's initial metabolic state.